Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based…

Overview of attention for article published in Annals of Hematology, April 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 68 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

PREDICTING RESPONSE TO IMMUNOMODULATORY DRUGS (IMIDS) IN MULTIPLE MYELOMA PATIENTS

Application WO-2017138810-A3

World Intellectual Property Organisation (WIPO)